Value Dossier Development
Development of client-specific, country-tailored HTA value dossiers for diagnostic technologies, designed to support structured and credible payer and HTA interactions across markets.
Aimed To
Biotech
Diagnostics (IVD/CDx)
Market Access
Medical Affairs
HEOR
Regulatory
Strategy Teams
Challenge
Successful HTA and reimbursement discussions require robust, locally relevant value dossiers, yet companies often struggle to translate product-specific evidence into country-specific HTA narratives that meet payer expectations.
How It Works
- Translate client-specific clinical, economic, and RWE evidence into HTA-ready value arguments
- Adapt structure, comparators, and endpoints to country-specific HTA requirements
- Develop submission-ready value dossiers aligned with local payer expectations
Why Buy
Delivers high-quality, country-adapted value dossiers built on the client’s evidence base, strengthening payer interactions and increasing the likelihood of positive HTA and reimbursement outcomes.
